Related Experiment Video
Updated: Feb 12, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
Dysfunction of antigen processing and presentation by dendritic cells in cancer
Joanna Bandola-Simon1, Paul A Roche1
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States.
Effective anti-tumor immunity needs antigen-presenting cells (APCs) to control T cell function. Tumors create immunosuppressive environments, often due to APCs failing to present tumor antigens, hindering T cell responses.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Immunology
Background:
- Effective anti-tumor immunity relies on antigen-presenting cells (APCs) to coordinate CD4 and CD8 T cell functions.
- Tumors establish immunosuppressive microenvironments that shield them from immune detection.
- A key defect involves APCs, particularly dendritic cells (DCs), failing to process and present tumor antigens to T cells.
Purpose of the Study:
- To review the critical roles of various dendritic cell (DC) subsets in anti-tumor immunity.
- To summarize the mechanisms tumors employ to suppress APC function.
- To highlight the importance of APCs in initiating anti-tumor T cell responses.
Main Methods:
- Literature review of studies on DC subsets and anti-tumor immunity.
- Analysis of tumor-induced immunosuppression mechanisms affecting APCs.
- Synthesis of research on APC-T cell interactions in the tumor microenvironment.
Main Results:
- Different DC subsets play distinct roles in initiating and regulating anti-tumor immune responses.
- Tumor cells utilize diverse strategies to inhibit DC maturation, antigen presentation, and T cell activation.
- Impaired APC function is a common hallmark of tumor-induced immune evasion.
Conclusions:
- Restoring or enhancing APC function is crucial for overcoming tumor-induced immunosuppression.
- Targeting tumor evasion mechanisms that suppress APCs holds therapeutic potential for cancer immunotherapy.
- Understanding DC subset-specific functions is key to developing effective anti-tumor strategies.
Related Concept Videos
Processes of Self-Presentation
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Self-Presentation: Self-Monitoring and Self-Handicapping
Self-Presentation
Strategies of Self-Presentation I: Strategic Self-Presentation
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...

